These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23709232)

  • 1. Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy.
    Patel PJ; Khera AV; Wilensky RL; Rader DJ
    Eur J Heart Fail; 2013 Nov; 15(11):1215-9. PubMed ID: 23709232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease.
    Patel PJ; Khera AV; Jafri K; Wilensky RL; Rader DJ
    J Am Coll Cardiol; 2011 Nov; 58(20):2068-75. PubMed ID: 22051328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.
    Shao B; Tang C; Sinha A; Mayer PS; Davenport GD; Brot N; Oda MN; Zhao XQ; Heinecke JW
    Circ Res; 2014 May; 114(11):1733-42. PubMed ID: 24647144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.
    Khera AV; Cuchel M; de la Llera-Moya M; Rodrigues A; Burke MF; Jafri K; French BC; Phillips JA; Mucksavage ML; Wilensky RL; Mohler ER; Rothblat GH; Rader DJ
    N Engl J Med; 2011 Jan; 364(2):127-35. PubMed ID: 21226578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Density Lipoprotein Particles, Cell-Cholesterol Efflux, and Coronary Heart Disease Risk.
    Asztalos BF; Horvath KV; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2007-2015. PubMed ID: 30002062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.
    Ishikawa T; Ayaori M; Uto-Kondo H; Nakajima T; Mutoh M; Ikewaki K
    Atherosclerosis; 2015 Sep; 242(1):318-22. PubMed ID: 26246268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested Case-Control Study.
    Soria-Florido MT; Castañer O; Lassale C; Estruch R; Salas-Salvadó J; Martínez-González MÁ; Corella D; Ros E; Arós F; Elosua R; Lapetra J; Fiol M; Alonso-Gómez A; Gómez-Gracia E; Serra-Majem L; Pintó X; Bulló M; Ruiz-Canela M; Sorlí JV; Hernáez Á; Fitó M
    Circulation; 2020 Feb; 141(6):444-453. PubMed ID: 31941372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metrics of High-Density Lipoprotein Function and Hospital Mortality in Acute Heart Failure Patients.
    Potočnjak I; Degoricija V; Trbušić M; Terešak SD; Radulović B; Pregartner G; Berghold A; Tiran B; Marsche G; Frank S
    PLoS One; 2016; 11(6):e0157507. PubMed ID: 27304214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease.
    Hancock-Cerutti W; Millar JS; Valentini S; Liu J; Billheimer JT; Rader DJ; Cuchel M
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients With Coronary Endothelial Dysfunction Have Impaired Cholesterol Efflux Capacity and Reduced HDL Particle Concentration.
    Monette JS; Hutchins PM; Ronsein GE; Wimberger J; Irwin AD; Tang C; Sara JD; Shao B; Vaisar T; Lerman A; Heinecke JW
    Circ Res; 2016 Jun; 119(1):83-90. PubMed ID: 27114438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.
    Norimatsu K; Kuwano T; Miura SI; Shimizu T; Shiga Y; Suematsu Y; Miyase Y; Adachi S; Nakamura A; Imaizumi S; Iwata A; Nishikawa H; Uehara Y; Saku K
    Heart Vessels; 2017 Jan; 32(1):30-38. PubMed ID: 27106918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.
    Li XM; Tang WH; Mosior MK; Huang Y; Wu Y; Matter W; Gao V; Schmitt D; Didonato JA; Fisher EA; Smith JD; Hazen SL
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1696-705. PubMed ID: 23520163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes.
    Hafiane A; Jabor B; Ruel I; Ling J; Genest J
    Am J Cardiol; 2014 Jan; 113(2):249-55. PubMed ID: 24210679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of links between high-density lipoprotein genetics, functionality, and aortic valve stenosis risk in humans.
    Arsenault BJ; Dubé MP; Brodeur MR; de Oliveira Moraes AB; Lavoie V; Kernaleguen AE; Guauque-Olarte S; Mathieu P; Pibarot P; Messika-Zeitoun D; Bossé Y; Rhainds D; Rhéaume E; Tardif JC
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):457-62. PubMed ID: 24334872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
    Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Insights of ANGPTL-3 on Modulating Cholesterol Efflux Capacity Induced by HDL Particle.
    Lai M; Jiang X; Wang B; Cheng Y; Su X
    Curr Mol Med; 2024; 24(6):771-779. PubMed ID: 37073658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cigarette smoking cessation on high-density lipoprotein functionality.
    Takata K; Imaizumi S; Kawachi E; Suematsu Y; Shimizu T; Abe S; Matsuo Y; Tsukahara H; Noda K; Yahiro E; Zhang B; Uehara Y; Miura S; Saku K
    Circ J; 2014; 78(12):2955-62. PubMed ID: 25319317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative tyrosylation of high density lipoproteins impairs cholesterol efflux from mouse J774 macrophages: role of scavenger receptors, classes A and B.
    Suc I; Brunet S; Mitchell G; Rivard GE; Levy E
    J Cell Sci; 2003 Jan; 116(Pt 1):89-99. PubMed ID: 12456719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased electronegativity of high-density lipoprotein in uremia patients impairs its functional properties and is associated with the risk of coronary artery disease.
    Chang CT; Shen MY; Hsieh JY; Chang CM; Liao HY; Chen FY; Hsu CY; Yang CY; Chen CJ
    Atherosclerosis; 2018 Nov; 278():147-155. PubMed ID: 30278357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.